Canada Pension Plan Investment Board’s GSK GSK Stock Holding History

Canada Pension Plan Investment Board’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-188,000	Closed	-$11M	–	1367
2019 Q4	$11M	Buy	188,000 +120,000	+176%	+$6.67M	0.02%	428
2019 Q3	$3.63M	Buy	+68,000	New	+$3.5M	0.01%	732
2018 Q4	–	Sell	-108,000	Closed	-$5.42M	–	1313
2018 Q3	$5.42M	Sell	108,000 -13,920	-11%	-$707K	0.01%	800
2018 Q2	$6.14M	Buy	+121,920	New	+$6.14M	0.01%	743
2013 Q4	–	Sell	-44,238	Closed	-$2.77M	–	1245
2013 Q3	$2.77M	Hold	44,238	–	–	0.01%	608
2013 Q2	$2.76M	Buy	+44,238	New	+$2.81M	0.01%	549

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Canada Pension Plan Investment Board's GSK Position: Q1 2020 in Review

Canada Pension Plan Investment Board sold out of GSK (GSK) in Q1 2020, closing a stake of 188,000 shares — an estimated $11M sold.

Canada Pension Plan Investment Board first reported a position in GSK in Q2 2013 and held it in 6 quarters. The position peaked at $11M in Q4 2019. 817 funds tracked by Wall St. Rank hold GSK as of Q1 2020.

Canada Pension Plan Investment Board reported no remaining GSK position as of Q1 2020 after selling out during the quarter.
Canada Pension Plan Investment Board sold 188,000 GSK shares in Q1 2020, an estimated $11M.
Canada Pension Plan Investment Board first reported a position in GSK in Q2 2013 and held it in 6 quarters.
Canada Pension Plan Investment Board's GSK position peaked at $11M in Q4 2019.
817 funds tracked by Wall St. Rank held GSK as of Q1 2020.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2020, filed 13 May 2020.